CDC braces for shortage after tetanus shot discontinued
The CDC wants doctors to conserve shots of one type of tetanus vaccine, after MassBiologics stopped making TdVax.
Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers the Biden administration's public health agencies, including the federal response to infectious disease outbreaks like COVID-19. Previously, he was a campaign reporter for CBS News based out of Las Vegas, where he was raised. He covered presidential, Senate and House candidates for the 2020 election cycle in Arizona, California, Nevada and New Mexico. He has also worked in Washington for "Face the Nation" and in New York for the "CBS Evening News." Tin graduated from Columbia University in 2017 with a bachelor's degree in political science.
The CDC wants doctors to conserve shots of one type of tetanus vaccine, after MassBiologics stopped making TdVax.
The FDA's new regulations are due to be published this year.
The CDC is reportedly weighing a revision to COVID-19 guidance which could allow people who test positive to return to work sooner.
Generic versions of the ADHD medications Adderall, Vyvanse, and Concerta remain in shortage in 2024.
Ecuador's authorities allege that Carlos Aguilera, a cinnamon grinder in that country, is "the likely source" of the contaminated spices that led to the recall of WanaBana applesauce.
Early data suggests the COVID vaccines have effectiveness against the recent JN.1 variant.
Health officials have warned for years about a growing syphilis epidemic, and 2022 had the highest numbers in decades.
FDA testing found "extremely high levels of lead contamination" in the cinnamon applesauce pouches, which have been recalled.
More than 8 in 10 cases of COVID-19 are now estimated to be the JN.1 variant.
Ozempic and other GLP-1 RA drugs, including Wegovy, Mounjaro and Zepbound, are being scrutinized.
Reckitt/Mead Johnson Nutrition issued a voluntary recall for Nutramigen Hypoallergenic Powdered Infant Formula products over concerns of possible bacterial contamination.
The prevalence of the JN.1 variant of COVID-19 looks to be highest in New York and New Jersey, where it makes up more than half of cases.
Most COVID-19 symptoms and guidelines for testing and treatment remain largely unchanged as cases from the JN.1 variant rise.
The JN.1 variant of COVID-19 is spreading, but health officials say the symptoms are not more severe and the added public health risk is "low."
Cinnamon used in the applesauce pouches was contaminated with "extremely high" lead levels.